Gyre Therapeutics (GYRE) traded up 3.76 % during a 24 hours period ending at 03:35 AM Central Europe on Wednesday 28th. One Gyre Therapeutics stock can currently be bought for about USD 6.53 on popular exchanges. Current supply of Gyre Therapeutics stocks is 106 mn. Gyre Therapeutics has a current market capitalization of USD 615 mn and approximately USD 566.9 k worth of Gyre Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Gyre Therapeutics has traded -18.96 % down. Simple moving average of last 200 days is at USD 7.02. The highest price of past 52 weeks was recorded at USD 9.14 on 03/05/2026. 52 weeks low was at USD 5.44 on 06/02/2026.
Here is how related stocks have performed in the past 24 hours:
Sturm Ruger & (RGR) traded down -0.02 % and now trades at USD 46.31. Current market capitalisation for Sturm Ruger & is USD 728.5 mn. Sturm Ruger & has a current price to earnings ratio of 60.39.
Cytek Biosciences (CTKB) traded up 5.37 % and now trades at USD 5.98. Current market capitalisation for Cytek Biosciences is USD 729.2 mn.
Hertz Global (HTZ) traded down -4.9 % and now trades at USD 1.99. Current market capitalisation for Hertz Global is USD 727.2 mn.
Frequency Electronics (FEIM) traded up 4.83 % and now trades at USD 70.72. Current market capitalisation for Frequency Electronics is USD 725.6 mn. Current price/earnings ratio for Frequency Electronics is 241.87.
Mesa Laboratories (MLAB) traded up 0.94 % and now trades at USD 129.25. Current market capitalisation for Mesa Laboratories is USD 727.4 mn. Current price/earnings ratio for Mesa Laboratories is 148.84.
About Gyre Therapeutics
Gyre Therapeutics, Inc. is a bio-pharmaceutical company that specializes in the development and commercialization of hydronidone (F351) for the treatment of metabolic dysfunction associated steatohepatitis.